News
-
-
-
COMMUNIQUÉ DE PRESSE
Zomedica Launches Enhanced Equine Insulin Assay for the TRUFORMA(R) Diagnostic Platform Featuring an Extended Range and Automatic Sample Dilution
Zomedica Corp. updates TRUFORMA Platform with widest dynamic range & automatic sample dilution for equine insulin test, improving point of care diagnostics -
-
-
COMMUNIQUÉ DE PRESSE
Zomedica Unveils Exclusive Fourth Friday at Four Webinar Series to Explore Cutting-Edge Veterinary Innovations
Zomedica launches monthly webinar series showcasing innovative products, expert insights, and growth opportunities in animal health. Sessions to feature game-changing technologies for veterinarians, investors, and industry leaders -
-
-
COMMUNIQUÉ DE PRESSE
Zomedica Announces First Quarter 2025 Financial Results: Revenue of $6.5 Million; 68% Gross Margin, and $65 Million in Liquidity to Support Growth
Zomedica Corp. reports record revenue growth in Q1 2025, driven by strong performance of PulseVet® and TRUFORMA® products. International sales up 32% -
